Study of T-PRED(TM) Compared to Pred Forte(R)

Bausch + Lomb

Status and phase: Completed; Phase 2

Conditions: Cataract

Treatments: Drug: T-PRED; Drug: Pred Forte

Study type: Interventional

Funder types: Industry

Identifiers

NCT00699803

CL-PKT-0312081-P

Details and patient eligibility

About

Study of T-PRED(TM) compared to Pred Forte(R)

Enrollment: 64 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years of age

Exclusion criteria

• No active or adverse disease

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Quadruple Blind

---

64 participants in 2 patient groups

T-Pred

Active Comparator group

Description:

Tobramycin prednisolone acetate combination

Treatment:

Drug: T-PRED

Pred Forte

Active Comparator group

Description:

Prednisolone acetate

Treatment:

Drug: Pred Forte